MVASI FDA approval date

The FDA approved MVASI on 14 Sep 2017.

FDA approval date
14 Sep 2017

Drug identity has not yet been verified against registry records

Also recorded as BEVACIZUMAB-AWWB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-09-14DayMVASIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761028", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["MVASI"], "active_ingredients": ["BEVACIZUMAB-AWWB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170914", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026